Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06444503
Other study ID # RC31/24/0214
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date August 2024
Est. completion date August 2034

Study information

Verified date May 2024
Source University Hospital, Toulouse
Contact Thomas EDOUARD, MD
Phone 05 61 77 61 10
Email edouard.t@chu-toulouse.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this project is to set up a biological and clinical collection of patients with progressive bone, calcium and growth plate pathologies. This collection will provide a better understanding of the mechanisms involved in growth plate and bone damage in these diseases and identify factors predictive of progression and new therapeutic targets.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 350
Est. completion date August 2034
Est. primary completion date August 2034
Accepts healthy volunteers No
Gender All
Age group 0 Years to 99 Years
Eligibility Inclusion Criteria: - Children (from birth) with growth plate or bone pathology - Patients affiliated to or benefiting from a social security scheme - Patients able to receive information about the study and to understand the information form in order to participate in the study. This implies : - mastery of the French language - Not being subject to a restriction of rights by the judicial authorities - Patients or legal representatives having given their consent to participate in the study (expression of non-opposition). Exclusion Criteria: - Patients under legal protection (guardianship, curatorship or safeguard of justice) - Pregnant or breast-feeding women

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Biological
Blood and urine will be taken in larger quantity
Biological
Surgical residues may be preserved in the event of surgery carried out as part of the treatment.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Toulouse

Outcome

Type Measure Description Time frame Safety issue
Primary Building a collection of biological samples and clinical-biological data from patients presenting bone, calcium and growth plate pathologies Blood and urine sampling Day 0 and through study completion, an average of 5 years
Secondary Identification of potential markers of disease progression based on new knowledge. Day 0 and through study completion, an average of 5 years
See also
  Status Clinical Trial Phase
Completed NCT03527511 - Effect of Active Vitamin D and Etelcalcetide on Human Osteoclasts in Patients With Chronic Kidney Disease
Recruiting NCT01166854 - Characterization of Familial Myopathy and Paget Disease of Bone